#Melanoma Research Alliance

Researchers have recently made progress in understanding what causes some types of resistance to immunotherapies.

Refining algorithms by incorporating more images of people of color can teach AI to better diagnose melanoma and other skin cancers.

This is the first investigational therapy in a Phase III trial to improve overall survival in uveal melanoma,” a cancer of the eye.

Their startup, Modern Ritual, offers skin care products and an at-home skin cancer screening that uses dermascopes and cell phones.

Camille Price’s life changed when a small spot on her ear was diagnosed as Stage 3 melanoma. Next came targeted therapy—and a marathon.

Despite its frequent grey and rainy weather, Oregon is among the top ten states with the highest rates of new melanoma skin cancer.

“It is a really important development for our patients."

People with melanoma can modify lifestyle factors such as diet, stress and the gut microbiome to improve treatment outcomes.

Latinos are less likely than their white counterparts to have melanoma, but when diagnosed, their cancer is usually more advanced.

“It truly is great news”: Findings show that patients with BRAF-mutant melanoma start treatment with combination immunotherapy. [VIDEOS]

Researchers explored challenges and opportunities for research on rare melanomas at the 2021 Melanoma Research Alliance Scientific Retreat.

Cancer vaccines become much more potent in their cancer-fighting abilities when combined with more established immunotherapies.

The MSNBC anchor revealed that she had surgery for skin cancer and made a passionate plea for everyone to get screened for the disease.

In early experiments, researchers found that “the antibiotics [could] buy the precious time needed for immunotherapy to kick in.”

At Melanoma Research Alliance’s 2021 Scientific Treat, scientists discussed enhancing anti-tumor immune response of combination therapies.

Researchers provide updates on the clinical trial of a new drug to improve the long-term survival of patients facing advanced melanoma